Cargando…

Androgen Therapy in 70 Cases of Advanced Mammary Carcinoma

Detalles Bibliográficos
Autor principal:	Galton, D. A. G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1950
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2007706/ https://www.ncbi.nlm.nih.gov/pubmed/15420325

Ejemplares similares

Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer
por: Liu, Chengfei, et al.
Publicado: (2018)

The Effects of Androgens on Induced Mammary Tumours in Rats
por: Young, Stretton, et al.
Publicado: (1965)

Principles of Therapy in Leukaemia
por: Galton, D. A. G.
Publicado: (1969)

The role of androgens in experimental rodent mammary carcinogenesis
por: Choi, Jaesung, et al.
Publicado: (2014)

Induction of Programmed Death/Apoptosis in Androgen‐dependent Mouse Mammary Tumor Cell Line (Shionogi Carcinoma 115) by Androgen Withdrawal
por: Furuya, Yuzo, et al.
Publicado: (1995)

Androgen deprivation therapy for androgen receptor‐positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands
por: Boon, Eline, et al.
Publicado: (2017)

Mammary Carcinoma
por: Ray, P. N.
Publicado: (1950)

Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy
por: Ben-David-Naim, Meital, et al.
Publicado: (2019)

Androgen Deprivation Therapy for Patients with Androgen-Receptor-Positive Metastatic Salivary Duct Carcinoma: A Case Report and Review of the Literature
por: You, Yongfei, et al.
Publicado: (2021)

Emerging Biomarkers and Targeted Therapies in Feline Mammary Carcinoma
por: Gameiro, Andreia, et al.
Publicado: (2021)

Inhibitory Effect of a Somatostatin Analogue (SMS 201–995) on the Growth of Androgen‐dependent Mouse Mammary Tumor (Shionogi Carcinoma 115)
por: Noguchi, Shinzaburo, et al.
Publicado: (1993)

Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer
por: Dagher, Elie, et al.
Publicado: (2019)

Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines
por: Shore, Neal D., et al.
Publicado: (2020)

Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy
por: Chen, Jia-Feng, et al.
Publicado: (2019)

Selective androgen receptor modulators: the future of androgen therapy?
por: Christiansen, Andrew R., et al.
Publicado: (2020)

Androgen Receptor in Laryngeal Carcinoma: Could There Be an Androgen-Refractory Tumor?
por: Goulioumis, Anastasios K., et al.
Publicado: (2011)

Francis Galton: His Approach to Polygenic Disease
por: Galton, D J, et al.
Publicado: (1997)

Acquisition of resistance to androgen deprivation therapy in salivary duct carcinoma: A case report
por: Wasano, Koichiro, et al.
Publicado: (2018)

Androgen Deprivation Therapy for Intracranial Metastasis of a Salivary Duct Carcinoma: Case Report
por: Rösch, Manuel, et al.
Publicado: (2023)

The Curability of Mammary Carcinoma
Publicado: (1898)

Possibility of in vitro Alterations in Cultures of Mammary Carcinoma Cells, and Altered Immunological Response in the Rat: Acquired Capacity to Reject Injections of Mammary Carcinoma Cells and Implants of Mammary Carcinoma
por: Stone, David, et al.
Publicado: (1972)

Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer
por: Kohli, Manish, et al.
Publicado: (2012)

Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy
por: Rajan, Prabhakar, et al.
Publicado: (2014)

The Induction of Mammary Carcinoma in the Rat
por: Nelson, Warren O.
Publicado: (1944)

Predictive factor of androgen deprivation therapy for patients with advanced stage prostate cancer
por: Kongseang, Chaiyut, et al.
Publicado: (2017)

Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor
por: Eftekharzadeh, Bahareh, et al.
Publicado: (2019)

A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma
por: Fushimi, C, et al.
Publicado: (2018)

Androgen deprivation therapy and fracture risk in Chinese patients with prostate carcinoma
por: Lee, Chi-Ho, et al.
Publicado: (2017)

Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer
por: Mason, Malcolm D., et al.
Publicado: (2015)

Relugolix: a novel androgen deprivation therapy for management of patients with advanced prostate cancer
por: Saad, Fred, et al.
Publicado: (2021)

Multimodal therapy for locally advanced prostate cancer: the roles of radiotherapy, androgen deprivation therapy, and their combination
por: Lee, Sung Uk, et al.
Publicado: (2017)

Carcinoma of the Male Mammary Gland
por: Beatson, George Thos.
Publicado: (1911)

THE EFFECT OF ADVANCE IN LACTATION AND GESTATION ON MAMMARY ACTIVITY
por: Gaines, W. L., et al.
Publicado: (1926)

Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer
por: Denmeade, Samuel R, et al.
Publicado: (2023)

Reduction of Dose to the Contralateral Breast by Superflab Use in Radiation Therapy for Mammary Carcinomas
por: Solanki, Akanksha, et al.
Publicado: (2017)

Male mammary gland development after apatinib therapy in advanced gastric cancer: A case report
por: Hui, Yan, et al.
Publicado: (2020)

On the Bimodal Age Distribution of Mammary Carcinoma
por: de Waard, F., et al.
Publicado: (1960)

In vitro cellular immunity in mammary carcinoma.
por: Jones, B. M., et al.
Publicado: (1974)

Case for diagnosis. An exophytic plaque on the chest. Carcinoma of the mammary crease()()
por: Yáñez-Díaz, Sonsoles, et al.
Publicado: (2021)

Embryonal carcinoma in androgen insensitivity syndrome
por: Barmon, Debabrata, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_h40jg3b4e2kmiih1b4u61c7hdo